Identifying opportunities for health care disinvestment Valentín-López B, Fernández de Larrea N, Callejo-Velasco D, López-Pedraza MJ, Maeso-Martínez S, Blasco-Amaro JA Experiences and methods review Health Technology Assessment Unit (UETS), Madrid, SPAIN Health Technology Assessment International Bilbao, 23-27 June 2012
16
Embed
Disinvestment. Identifying opportunities for health care disinvestment.
Identifying opportunities for health care disinvestment. Experiences and methods review. Valentín-López B, Fernández de Larrea N, Callejo-Velasco D, López-Pedraza MJ, Maeso-Martínez S, Blasco-Amaro JA.
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Identifying opportunities for health care disinvestment
Identifying opportunities for health care disinvestment
Valentín-López B, Fernández de Larrea N, Callejo-Velasco D, López-Pedraza MJ, Maeso-Martínez S, Blasco-Amaro JA
Experiences and methods reviewExperiences and methods review
Health Technology Assessment Unit (UETS), Madrid, SPAIN
Health Technology Assessment International Bilbao, 23-27 June 2012
Disinvestment: withdrawing existing
health care resources that provide little
clinical value for money
Opportunity for reinvestment resources in
cost-effective interventions
Sustainability of health care system-
increase delivering effective treatments
IntroductionIntroduction
ObjectivesObjectives
To identify health care practices &
technologies of uncertain effectiveness,
safety and efficiency for disinvestment
To review methods and experiences to
identify and prioritise ineffective health
care interventions
MethodologyMethodology
Literature review
Databases: HTA CRD, Cochrane, Medline, ISI wok
Institutions: NICE, NHS, HTAi, SHTG, AHRQ
Key words: disinvestment or obsolete or ineffective
Integrate disinvestment in clinical agendaIdentify interventions no longer effective/worthy
Technology Cost: significant budget impact
Effective alternatives of demonstrated cost-effectiveness
Technology elimination may reduce risks to patient safety
Disinvestment impact not target at vulnerable population
Technologies with small benefits, not life-threatening conditions
Products: Recommendation reminders
Criteria to prioritize technologies
NICENICE
800 “Do not do” recommendations database
Type of guidance Interventions NICE “do not do” recommendation
Clinical guidelines
CG osteoarthritis
Electro-acupuncture
Glucosamine/chondroitin products
Electro-acupuncture should not be used to treat people with osteoarthritis
Use of chondroitin/glucosamine products is not recommended for the treatment of osteoarthritis
Interventional procedures
arthroscopic knee washout alone
Arthroscopic knee washout alone should not be used as a treatment for osteoarthritis because it cannot demonstrate clinically useful benefit in the short or long term
Technology appraisals guidance
Abatacept
Abatacept in combination with methotrexate
Abatacept is not recommended for treatment of rheumatoid arthritis
Abatacept with methotrexate is not recommended for treatment of moderate to severe active rheumatoid arthritis whose has responded inadequately to DMARDs